Welcome

On behalf of the World Federation of Hemophilia and the Congress Organizing Committee, we warmly invite you to attend the Hemophilia World Congress in Vancouver from May 21-25, 2006.
For more up to date information visit: World Federation of Hemophilia

Program

Each congress day will begin with two plenary sessions by some of the world's most distinguished researchers, physicians and community leaders.

The four congress days will include three 90-minute concurrent sessions, which will include state-of-the-art symposia, peer-reviewed abstract sessions and “Meet the Experts” sessions as part of the congress program tracks listed below.

CME Credits

CONTINUING MEDICAL EDUCATION CREDITS (CME)

The XXVII International Congress of the World Federation of Hemophilia is approved for up to 24 credits by the Centre for Continuing Medical Education.

About Vancouver

Vancouver is nestled between rugged Coastal Range Mountains and the brilliant blue Pacific Ocean. It has been described as one of the most spectacularly situated cities on earth.

 

Detailed Program

Program
Each congress day will begin with two plenary sessions led by some of the world’s most distinguished researchers, physicians and community leaders.
The rest of each of the four congress days will be divided into three 90-minute concurrent sessions with 6 tracks, which will include state-of-the-art symposia, peer-reviewed abstract sessions and “Meet the Experts” sessions.
Delegates are encouraged to attend sessions outside their areas of expertise to enhance their knowledge of all aspects of hemophilia care.
click here for Detailed Congress Schedule
SESSION TRACKS include:
Plenary Sessions
Medical Sessions
Laboratory Science Sessions
Dental Sessions
Multidisciplinary Sessions
Capacity Building Sessions
Meet the Experts
Musculoskeletal Issues
PLENARY SESSIONS
Mr. Mark W. Skinner, U.S.A.
Building for the Future: Facing the Challenges, Seizing the Opportunities
Dr. Robert Montgomery, U.S.A.
Molecular Basis of von Willebrand Disease
Dr. Pier Luigi Solimeno, Italy
Musculoskeletal Issues: Total Joint Replacements in Patients with Inhibitors
Dr. Goris Roosendaal, Netherlands
Pathogenesis of Hemophilic Arthropthy
Dr. Steven Pipe, U.S.A.
Strategies Towards a Longer-Acting Factor VIII
Dr. Michael J. Paidas, U.S.A.
The Uterus: A Recycling Model for the Physiology of Coagulation and Fibrinolysis
Dr. Jan Astermark, Sweden
Why do Inhibitors Develop? Principles of and factors influencing the risk for inhibitor development in hemophilia
Dr. Bruce Evatt, U.S.A.
Future of Comprehensive Care Centres for Hereditary Coagulation Disorders
MEDICAL SESSIONS (back to top)
will discuss the latest scientific developments and progress in research diagnosis, treatment and care of people living with hemophilia. The medical sessions are not primarily aimed for a lay audience.
1. Quality of Life
Alessandro Gringeri, Italy
2. Prophylaxis
Victor Blanchette, Canada
11. Gyn/Obs Management of Women with Inherited Bleeding Disorders
Peter Kouides, U.S.A.
3. Pharmacokinetics and Pharmacoeconomics in Hemophilia Care
Martin Lee, U.S.A.
12. Blood Product Safety, Supply and Affordability
David Page, Canada
4. Ethical Issues in Hemophilia
Donna DiMichele, U.S.A.
13. Rare Bleeding Disorders
Flora Peyvandi, Italy
5. Arosenius Lecture: Cellular and Genetic Therapies
David Lillicrap, Canada
14. Congenital Platelet Disorders
C. Hayward, Canada
6. Von Willebrand Disease - Clinical Management
Augusto Federici, Italy
15. Novel Therapies for Hemophilia
Akira Yoshioka, Japan
7. Debate on Current Issues in Immune Tolerance
Charles Hay, U.K.
16. Medical Twinning Program
Alison Street, Australia
8. Understanding Why and When Inhibitors Develop
Kathelijne Peerlinck, Belgium
17. ESCHQoL
Wolfgang Schramm
18. Free Paper 1
9. Infectious Disease Update
Christos Tsoukas
19. Free Paper 2
20. Free Paper 3
10. Hemophilia & Aging
Alison Street, Australia
21. Free Paper 4
LAB SCIENCE SESSIONS (back to top)
Laboratory Science Sessions will feature presentations on quality assurance, laboratory diagnosis including genetic testing as well as experiences of laboratory diagnosis in developing countries.
1. Achieving and Maintaining Quality in the Laboratory
M. Hertzberg, Australia
Eric Preston, U.K.
3. New Approaches for Measuring Coagulation
Trevor Barrowcliff, U.K.
2. Laboratory Issues in Bleeding Disorders
Augusto Federici, Italy
4. Genetic Diagnosis of Hemophilia
Flora Peyvandi, Italy
DENTAL SESSIONS(back to top)
will discuss the latest advances and new approaches to dental care in hemophilia patients.
1. Oral Surgery Based Problems
Andrew Brewer, U.K.
2. Restorative Dentistry
Monthon Suwannuraks
MULTIDISCIPLINARY SESSIONS (back to top)
will include topics of special interest to members of national hemophilia organizations, nurses, social workers, and psychologists. The sessions will explore psychosocial issues, socio-economic issues, and access to care and care delivery issues.
1. Implementing National Models of Care Through the
WFH GAP Magdy El-Ekiaby, Egypt
11. Strategies for Easing the Socio-Economics Impact of Bleeding Disorders on Families Ruud Bos, Netherlands
2. Strategies to Introduce, Maintain or Improve Hemophilia Care
Brian O'Mahony, Ireland
12. Quality of Life Research
Sylvia Von Mackensen, Italy
3. Psychosocial Issues Related to HIV/HCV Infection
Maureen Spilsbury, Australia
13. Treatment of Inhibitors from a Multidisciplinary Perspective
Sylvie Lacroix, Canada
4. Issues in Adolescence
Kelly Green, U.S.A.
14. Venous Access: Current Management
Vicky Vidler, U.K.
5. Pain Management for
Children and Adults
Pam Wilton, Canada 15. Patient / Healthcare Provider Relationships
Shahla Sohail, Pakistan
6. Issues for Carriers
Lara Oyesiku, U.K.
16. Family Dynamics
Paul Scott, South Africa
7. Women's Concerns Around Their Own Bleeding Disorders
Ann-Marie Nazzaro, U.S.A.
17. Factors that Effect Access and Adherence to Treatment: A Global Perspective
Mirriam Mokwena, South Africa
8. Wrinkles and Old Bones: Issues for Those Over 50
Mike Carnahan, New Zealand
18. Burnout
Edward Kuebler
9. Tools to Enhance Care
Hanne Thykjar , Denmark
10. Musculoskeletal Issues Through the Generations
Kathy Mulder, Canada
19. Gene Therapy - Multidisciplinary Perspective
John Pasi
19. Free Paper 1
Aris Hashim, Malaysia
20. Free Paper 2
Ali Tchupan
CAPACITY BUILDING SESSIONS(back to top)
are targeted to the hemophilia community for people working in patient organizations worldwide.
1. Recruiting Young People into National Member Organizations
Dorthe Lysgaard, Denmark
3. Opportunities and Challenges in Building Strong, National Member Organizations
Cesar Garrido, Venezuela
2. Building Alliances Outside the Bleeding Disorders Community / Intergrating New Patient Regulations
Gordon Clark, Northern Ireland
4. Fundraising Strategies in a Competitive Environement
Aris Hashim, Malaysia
MEET THE EXPERTS(back to top)
1. Pain Management
Mammen Chandy, India 2. Physio / Musculoskeletal Kathy Mulder, Canada 3. Inhibitors
Georges Rivard, Canada Donna DiMichele, USA 4. Prenatal Diagnosis and Obstetric Management
Andra James, USA Cathy Turner, U.K. 5. Dental
Andrew Brewer, U.K.
MUSCULOSKELETAL SESSIONS (back to top)
will be designed to encompass a broad spectrum of treatment and methods of managing Musculoskeletal complications of hemophilia.
Poster Sessions will be generated from peer-reviewed abstracts and will cover a wide variety of topics. Posters will be displayed during exhibit hours.